Kore Private Wealth’s iShares Biotechnology ETF IBB Stock Holding History

Kore Private Wealth’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	$256K	Sell	2,188 -66	-3%	-$8.2K	0.05%	210
2022 Q2	$265K	Buy	+2,254	New	+$268K	0.04%	236
2020 Q3	–	Sell	-2,093	Closed	-$286K	–	633
2020 Q2	$286K	Buy	2,093 +658	+46%	+$83.9K	0.06%	183
2020 Q1	$155K	Buy	1,435 +944	+192%	+$109K	0.04%	239
2019 Q4	$59K	Buy	+491	New	+$54.8K	0.01%	464
2019 Q2	–	Sell	-467	Closed	-$52K	–	487
2019 Q1	$52K	Sell	467 -43	-8%	-$4.72K	0.01%	380
2018 Q4	$49K	Buy	+510	New	+$54.1K	0.01%	375

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Commerce Bank Kansas City, Missouri $20.7B AUM 23.76% 1-Year Est. Return

Kore Private Wealth's IBB Position: Q3 2022 in Review

Kore Private Wealth reduced its iShares Biotechnology ETF (IBB) stake by 2.9% in Q3 2022, selling an estimated $8.2K and leaving 2,188 shares worth $256K. The position accounts for 0.05% of the portfolio, ranked #210.

Kore Private Wealth first reported a position in IBB in Q4 2018 and has held it in 7 quarters since. The position peaked at $286K in Q2 2020. 830 funds tracked by Wall St. Rank hold IBB as of Q3 2022.

Kore Private Wealth held 2,188 shares of iShares Biotechnology ETF worth $256K as of Q3 2022.
Kore Private Wealth sold 66 iShares Biotechnology ETF shares in Q3 2022, an estimated $8.2K.
iShares Biotechnology ETF made up 0.05% of Kore Private Wealth's portfolio in Q3 2022, its #210 holding.
Kore Private Wealth first reported a position in iShares Biotechnology ETF in Q4 2018 and has held it in 7 quarters since.
Kore Private Wealth's iShares Biotechnology ETF position peaked at $286K in Q2 2020.
830 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q3 2022.

Based on Kore Private Wealth's 13F filing for Q3 2022, filed 14 Nov 2022.